- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Updates, 06-07-2026: Press Release
06-07-2026 | 08:36 am
06-07-2026 | 08:36 am
Glenmark Pharma USA launched Olanzapine for Injection, a generic equivalent to Zyprexa®. This strengthens its injectables portfolio, targeting a market with annual sales of approximately $25.4 million. This move expands access to affordable treatments for patients.
No comments yet. Be the first to comment!